Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Fuji
Queensland Health
US Department of Justice
Dow
Medtronic
Moodys
Chinese Patent Office
McKinsey

Generated: April 19, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: dabrafenib mesylate

« Back to Dashboard

dabrafenib mesylate

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Novartis Pharms Corp TAFINLAR dabrafenib mesylate CAPSULE;ORAL 202806 NDA Novartis Pharmaceuticals Corporation N 0078-0681-66
Novartis Pharms Corp TAFINLAR dabrafenib mesylate CAPSULE;ORAL 202806 NDA Novartis Pharmaceuticals Corporation N 0078-0682-66
Novartis Pharms Corp TAFINLAR dabrafenib mesylate CAPSULE;ORAL 202806 NDA GlaxoSmithKline LLC N 0173-0846-08
Novartis Pharms Corp TAFINLAR dabrafenib mesylate CAPSULE;ORAL 202806 NDA GlaxoSmithKline LLC N 0173-0847-65
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Argus Health
Covington
Cerilliant
US Department of Justice
Fish and Richardson
US Army
Express Scripts
Citi